This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Testing New Method of Analyzing MR Images

This study has been terminated.
(Unable to accrue enough subjects to analyze data.)
Information provided by (Responsible Party):
Indiana University Identifier:
First received: February 28, 2008
Last updated: January 11, 2017
Last verified: January 2017
Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.

Condition Intervention Phase
Breast Abnormalities Device: MRI Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI

Resource links provided by NLM:

Further study details as provided by Indiana University:

Primary Outcome Measures:
  • To provide preliminary data for a larger study that this type of imaging can be used to monitor the effectiveness of anti-angiogenic therapy. [ Time Frame: After analysis of images ]

Enrollment: 12
Study Start Date: March 2008
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: MRI
    15-20 minutes MR imaging
Detailed Description:

The purpose of this study is to develop and evaluate new MR imaging techniques and protocols for non-invasive monitoring of anti-angiogenesis treatment of breast cancer. This feasibility study is a preliminary imaging study to test this imaging protocol on subjects already undergoing MR for clinical purposes.

The specific objective of this research study is to develop and validate both MRI and functional MRI data acquisition methods, task paradigms, and post-processing techniques to ensure reliability of results.

The information derived from this research is intended to be applied to a future study of subjects undergoing experimental anti-angiogenesis drug therapy.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Females
  • Age 18 years or greater
  • Undergoing breast MRI exam

Exclusion Criteria:

  • Pregnancy
  • Contraindication for MRI on standard screening checklist for clinically indicated examinations (i.e. metal devices/implants; history of claustrophobia)
  • History/presence of any of the following to the breast: injury; breast implant; surgical or interventional procedure; clinically significant abnormality
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00630318

United States, Indiana
Methodist Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Principal Investigator: Susan E. Clare, MD, Ph.D. Indiana University
  More Information

Responsible Party: Indiana University Identifier: NCT00630318     History of Changes
Other Study ID Numbers: 0710-67
Study First Received: February 28, 2008
Last Updated: January 11, 2017

Keywords provided by Indiana University:
MR scanning processed this record on August 18, 2017